Olivier Theodoly presented the MOHICAN, laureate of the PEPR MED-OOC call 2025. The MOHICAN project aims to develop new medical devices enabling functional testing of patient immune cells as part of routine hospital practice. These innovative devices will integrate microfluidic components coupled with microprinted molecular patterns to recreate structures that mimic secondary and tertiary lymph. The MOHICAN consortium brings together leading biophysics teams (LAI – Marseille and IINS – Bordeaux), clinical partners from AP-HM and IPC, as well as the TAGC genomics laboratory.
You must be logged in to post a comment.